Literature DB >> 25400818

Immunohistochemical characterization of brain-invasive meningiomas.

Thomas Backer-Grøndahl1, Bjørnar H Moen1, Magnus B Arnli1, Kathrin Torseth2, Sverre H Torp3.   

Abstract

Brain-invasive meningiomas have an adverse prognosis, so it is important to detect and correctly evaluate brain invasion by light microscopy. Furthermore, the underlying biological mechanisms responsible for brain-invasive growth are incompletely understood. The primary aim of this study was to identify immunohistochemical markers that could improve identification and evaluation of brain invasion in meningiomas. A second aim was to investigate the process of brain invasion using immunohistochemical markers of proliferation, extracellular matrix modulation, and cell adhesion. From a series of 196 human meningiomas, 67 cases were selected for analysis because of the presence of brain tissue in tumor specimens. Fourteen of these 67 meningiomas were brain-invasive. Invasiveness was determined primarily by evaluation of hematoxylin-erytrosin-saffron- (HES-) stained specimens, although glial fibrillary acidic protein (GFAP), anti-collagen IV, and cluster of differentiation 44 (CD44) markers provided additional information. It was important to examine microscopic sections from various levels of the paraffin-embedded tissue block to adequately assess invasiveness. Sections stained using antibodies against Ki-67/MIB-1, phospohistone-H3 (PHH3), matrix metalloproteinase-9 (MMP-9), cathepsin D, plasminogen activator inhibitor-1 (PAI-1), and E-cadherin antigens were used to characterize brain-invasive meningiomas and to investigate the process of brain invasion. Only increased expression of the extracellular matrix modulator MMP-9 correlated with brain-invasive growth (p=0.025). Examination of HES-stained sections identified brain invasion. Use of relevant immunohistochemical markers did not contribute substantially to this evaluation. Evaluation of stepwise sections should be considered when brain-invasive growth is suspected. MMP-9 may be an important mediator of brain-invasive growth.

Entities:  

Keywords:  CD4; E-cadherin; EMA; GFAP; Ki-67/MIB-1; MMP-9; PAI-1; PHH3; cathepsin D; collagen IV

Mesh:

Substances:

Year:  2014        PMID: 25400818      PMCID: PMC4230100     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  67 in total

Review 1.  Matrix metalloproteinases and tumor metastasis.

Authors:  Elena I Deryugina; James P Quigley
Journal:  Cancer Metastasis Rev       Date:  2006-03       Impact factor: 9.264

2.  Secretion of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by meningiomas detected by cell immunoblot analysis.

Authors:  T Mizoue; H Kawamoto; K Arita; A Tominaga; K Kurisu
Journal:  Acta Neurochir (Wien)       Date:  1999       Impact factor: 2.216

3.  MMP-9 expression in meningiomas: a prognostic marker for recurrence risk?

Authors:  V Barresi; E Vitarelli; G Tuccari; G Barresi
Journal:  J Neurooncol       Date:  2010-07-21       Impact factor: 4.130

Review 4.  Pathophysiological functions of cathepsin D: Targeting its catalytic activity versus its protein binding activity?

Authors:  Olivier Masson; Anne-Sophie Bach; Danielle Derocq; Christine Prébois; Valérie Laurent-Matha; Sophie Pattingre; Emmanuelle Liaudet-Coopman
Journal:  Biochimie       Date:  2010-05-21       Impact factor: 4.079

5.  Invasive meningioma is associated with a low expression of E-cadherin and beta-catenin.

Authors:  S Utsuki; H Oka; Y Sato; N Kawano; B Tsuchiya; I Kobayashi; K Fujii
Journal:  Clin Neuropathol       Date:  2005 Jan-Feb       Impact factor: 1.368

6.  Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion.

Authors:  Q Yu; I Stamenkovic
Journal:  Genes Dev       Date:  1999-01-01       Impact factor: 11.361

7.  Microscopic anatomy of the brain-meningioma interface.

Authors:  Satoshi Nakasu; Tadateru Fukami; Junya Jito; Masayuki Matsuda
Journal:  Brain Tumor Pathol       Date:  2005       Impact factor: 3.298

8.  Expression of cell adhesion proteins and proteins related to angiogenesis and fatty acid metabolism in benign, atypical, and anaplastic meningiomas.

Authors:  Alexandros Theodoros Panagopoulos; Carmen Lucia Penteado Lancellotti; José Carlos Esteves Veiga; Paulo Henrique Pires de Aguiar; Alison Colquhoun
Journal:  J Neurooncol       Date:  2008-04-17       Impact factor: 4.130

Review 9.  Meningioma.

Authors:  Ali-Reza Fathi; Ulrich Roelcke
Journal:  Curr Neurol Neurosci Rep       Date:  2013-04       Impact factor: 5.081

Review 10.  Epithelial-to-mesenchymal transition: possible role in meningiomas.

Authors:  Nives Pecina-Slaus; Tatjana Cicvara-Pecina; Anja Kafka
Journal:  Front Biosci (Elite Ed)       Date:  2012-01-01
View more
  19 in total

Review 1.  Prognostic significance of brain invasion in meningiomas: systematic review and meta-analysis.

Authors:  Satoshi Nakasu; Yoko Nakasu
Journal:  Brain Tumor Pathol       Date:  2021-01-06       Impact factor: 3.298

2.  WHO grade of intracranial meningiomas differs with respect to patient's age, location, tumor size and peritumoral edema.

Authors:  Anne Ressel; Susanne Fichte; Michael Brodhun; Steffen K Rosahl; Ruediger Gerlach
Journal:  J Neurooncol       Date:  2019-10-01       Impact factor: 4.130

Review 3.  Brain-invasive meningiomas: molecular mechanisms and potential therapeutic options.

Authors:  Chaoying Qin; Meng Huang; Yimin Pan; Yuzhe Li; Wenyong Long; Qing Liu
Journal:  Brain Tumor Pathol       Date:  2021-04-26       Impact factor: 3.298

Review 4.  Brain invasion in meningiomas-clinical considerations and impact of neuropathological evaluation: a systematic review.

Authors:  Benjamin Brokinkel; Katharina Hess; Christian Mawrin
Journal:  Neuro Oncol       Date:  2017-10-01       Impact factor: 12.300

5.  Clinical and pathological impact of an optimal assessment of brain invasion for grade 2 meningioma diagnosis: lessons from a series of 291 cases.

Authors:  Thiébaud Picart; Chloé Dumot; Jacques Guyotat; Vladislav Pavlov; Nathalie Streichenberger; Alexandre Vasiljevic; Tanguy Fenouil; Anne Durand; Emmanuel Jouanneau; François Ducray; Timothée Jacquesson; Moncef Berhouma; David Meyronet
Journal:  Neurosurg Rev       Date:  2022-04-29       Impact factor: 2.800

Review 6.  Meningioma Tumor Microenvironment.

Authors:  Sajad Sahab-Negah; Ali Gorji
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

7.  A prognostic cytogenetic scoring system to guide the adjuvant management of patients with atypical meningioma.

Authors:  Ayal A Aizer; Malak Abedalthagafi; Wenya Linda Bi; Margaret C Horvath; Nils D Arvold; Ossama Al-Mefty; Eudocia Q Lee; Lakshmi Nayak; Mikael L Rinne; Andrew D Norden; David A Reardon; Patrick Y Wen; Keith L Ligon; Azra H Ligon; Rameen Beroukhim; Ian F Dunn; Sandro Santagata; Brian M Alexander
Journal:  Neuro Oncol       Date:  2015-08-30       Impact factor: 12.300

8.  Microscopic brain invasion in meningiomas previously classified as WHO grade I is not associated with patient outcome.

Authors:  Annamaria Biczok; Christine Jungk; Rupert Egensperger; Andreas von Deimling; Bogdana Suchorska; Joerg C Tonn; Christel Herold-Mende; Christian Schichor
Journal:  J Neurooncol       Date:  2019-11-11       Impact factor: 4.130

9.  Impact of postoperative radiotherapy on recurrence of primary intracranial atypical meningiomas.

Authors:  Naureen Keric; Darius Kalasauskas; Christian F Freyschlag; Jens Gempt; Martin Misch; Alicia Poplawski; Nicole Lange; Ali Ayyad; Claudius Thomé; Peter Vajkoczy; Bernhard Meyer; Florian Ringel
Journal:  J Neurooncol       Date:  2020-01-03       Impact factor: 4.130

10.  Expression levels of β-catenin and galectin-3 in meningioma and their effect on brain invasion and recurrence: a tissue microarray study.

Authors:  Rehab Allah Ahmed; Abdelhadi M Shebl; Hany Onsy Habashy
Journal:  Cancer Biol Med       Date:  2017-08       Impact factor: 4.248

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.